Table 1.

ZnO-NPs have an antidiabetic impact in STZ-induced diabetic mice.

Groups	Dose	Blood glucose levels (mmol/L) fasting glucose levels	Glucose levels after 2 h	% of inhibition
Control distal water	1 mL/mice (oral)	19.46 ± 0.25	19.63 ± 0.29	—
NPs	14 mg/kg b.w. (oral)	19.28 ± 0.41	12.25 ± 0.19	48.63
NPs+insulin	7 mg/kg b.w.(oral) + 0.2 U/50 g (s.c.)	19.48 ± 0.26	14.63 ± 0.21	36.89
G-IV (standard: insulin)	0.4 U/50 g (s.c.)	19.57 ± 0.37	9.5.31 ± 0.48	55.71